Lipid accumulation and dendritic cell dysfunction in cancer.

Nature Medicine
Donna L HerberDmitry I Gabrilovich

Abstract

Dendritic cells (DCs), a type of professional antigen-presenting cells, are responsible for initiation and maintenance of immune responses. Here we report that a substantial proportion of DCs in tumor-bearing mice and people with cancer have high amounts of triglycerides as compared with DCs from tumor-free mice and healthy individuals. In our studies, lipid accumulation in DCs was caused by increased uptake of extracellular lipids due to upregulation of scavenger receptor A. DCs with high lipid content were not able to effectively stimulate allogeneic T cells or present tumor-associated antigens. DCs with high and normal lipid levels did not differ in expression of major histocompatibility complex and co-stimulatory molecules. However, lipid-laden DCs had a reduced capacity to process antigens. Pharmacological normalization of lipid abundance in DCs with an inhibitor of acetyl-CoA carboxylase restored the functional activity of DCs and substantially enhanced the effects of cancer vaccines. These findings suggest that immune responses in cancer can be improved by manipulating the lipid levels in DCs.

References

Jan 14, 1994·Cell·K A HogquistF R Carbone
Dec 24, 1997·Journal of Leukocyte Biology·P SandersonP C Calder
Feb 17, 2000·Arteriosclerosis, Thrombosis, and Vascular Biology·M P de WintherM H Hofker
Jan 16, 2002·Current Opinion in Immunology·Leanne PeiserSiamon Gordon
Apr 12, 2002·Journal of Controlled Release : Official Journal of the Controlled Release Society·E TouitouY Becker
Dec 23, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yulia NefedovaDmitry Gabrilovich
Dec 2, 2004·Nature Reviews. Immunology·Dmitry Gabrilovich
Feb 3, 2005·The Journal of Biological Chemistry·Maximilian ZeydaThomas M Stulnig
Apr 22, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Amy R WeatherillDaniel H Hwang
Apr 6, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Thorsten HagemannFrances R Balkwill
Dec 13, 2006·The American Journal of Clinical Nutrition·Saame Raza Shaikh, Michael Edidin
Feb 22, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ivan PerrotSerge Lebecque
May 2, 2007·Journal of Immunotherapy·Srinivas NagarajDmitry I Gabrilovich
Aug 4, 2007·Clinical Biochemistry·Ioannis DelimarisAmalia Dionyssiou-Asteriou
Feb 16, 2008·Immunity·Stella C Knight
Oct 4, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Je-In YounDmitry I Gabrilovich

❮ Previous
Next ❯

Citations

Nov 16, 2011·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Huanfa YiXiang-Yang Wang
Jun 23, 2012·Cancer Immunology, Immunotherapy : CII·Gabriela A PizzurroJosé Mordoh
Sep 14, 2010·Journal of Mammary Gland Biology and Neoplasia·Amanda W Lund, Melody A Swartz
Nov 2, 2012·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Carol A Colton
Dec 14, 2011·Animal Health Research Reviews·Yongming SangFrank Blecha
Sep 2, 2010·Cell Research·Philip C Calder
Mar 23, 2012·Nature Reviews. Immunology·Dmitry I GabrilovichVincenzo Bronte
Jul 31, 2013·The Journal of Experimental Medicine·Laura RaccostaVincenzo Russo
Aug 11, 2012·American Journal of Respiratory and Critical Care Medicine·Jingjing BenQi Chen
Nov 8, 2011·Immunotherapy·Judith LeiboviciJudith Sinai
Oct 16, 2013·Molecular Therapy : the Journal of the American Society of Gene Therapy·Tzu-Yang WengMing-Derg Lai
May 10, 2013·Nanomedicine·Wei LiYajun Guo
Feb 1, 2011·Therapeutic Delivery·Jhanelle Gray, Alberto Chiappori
Jan 31, 2014·Marine Drugs·Jong-Young Kwak
May 3, 2014·The Journal of Clinical Investigation·Thomas CondamineDmitry I Gabrilovich
Jan 12, 2011·Annual Review of Immunology·Matthew D VeselyMark J Smyth
Apr 23, 2013·The Journal of Biological Chemistry·Wentao QiSuzana D Savkovic
May 17, 2013·Metabolomics : Official Journal of the Metabolomic Society·Xiaoyan PanAndrew C Peet
Dec 12, 2013·Expert Review of Clinical Immunology·Alka Bhatia, Yashwant Kumar
Feb 10, 2016·Trends in Immunology·Vinit KumarDmitry I Gabrilovich
Feb 18, 2016·Journal for Immunotherapy of Cancer·Ping-Chih Ho, Pu-Ste Liu
Nov 28, 2012·Journal de gynécologie, obstétrique et biologie de la reproduction·S HanssenD Vinatier
Dec 10, 2015·Cancer Immunology, Immunotherapy : CII·Laura RaccostaVincenzo Russo
Aug 30, 2011·Biochemical and Biophysical Research Communications·Vladimir A TyurinValerian E Kagan
Mar 11, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·George MalietzisStella C Knight
Jul 24, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Daming ZuoXiang-Yang Wang
Mar 23, 2013·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Frank Tacke, Hiroyuki Yoneyama
Mar 18, 2016·Cancer Immunology, Immunotherapy : CII·Jinbao ZongMichael R Shurin
May 4, 2016·Oncoimmunology·Juan R Cubillos-Ruiz, Laurie H Glimcher
Aug 30, 2014·Clinical and Experimental Immunology·S R ShaikhH Teague
Dec 26, 2013·BioMed Research International·Wei LiYajun Guo

❮ Previous
Next ❯

Datasets Mentioned

BETA
GM-CSF

Methods Mentioned

BETA
flow cytometry
transgenic

Software Mentioned

GraphPad
GraphPad PRISM

Related Concepts

Related Feeds

Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.